Age and co-morbidity as risk factors for over-treatment of low-risk prostate cancer

In recent years, it has become increasingly well understood that patients diagnosed with low-risk prostate cancer are potentially susceptible to over-treatment. This is particularly the case among men who have significant degrees of co-morbidity and men greater than 75 years of age who have a life expectancy of < 15 years. … READ MORE …

Outcomes after surgery in men of 70 and older

The appropriateness of radical prostatectomy as a form of treatment of prostate cancer in men of 70 years of age and older has been questionned for all sorts of reasons over the years. … READ MORE …

Life exectancy, Charlson score, and outcomes in T3a prostate cancer

We had said we would get to this yesterday, but unfortunately (as it all too often does) life intervened. We apologize for the delay.

Anyway, European Association of Urology (EAU) guidelines indicate that a life expectancy of > 10 years is an important factor in the treatment of prostate cancer, and the so-called Charlson score is used to predict mortality based on comorbidities. … READ MORE …